Small tax-withholding sale by Health Catalyst (HCAT) CEO disclosed

Rhea-AI Filing Summary

Health Catalyst, Inc. CEO and director Albert Benjamin reported a mandated tax-withholding disposition of 336 shares of Common Stock on June 1, 2026 at an average price of $1.3702 per share. The shares were sold to cover tax withholding obligations arising from the vesting of Restricted Stock Units under the company’s equity incentive plans and were executed as a required "sell to cover" transaction, not a discretionary trade. After this transaction, Benjamin directly holds 1,458,456 shares of Common Stock.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Albert Benjamin

Role CEO

Type	Security	Shares	Price	Value
Tax Withholding	Common Stock	336	$1.3702	$460.39

Holdings After Transaction: Common Stock — 1,458,456 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

Tax-withholding shares: 336 shares Average price per share: $1.3702 per share Shares held after transaction: 1,458,456 shares +1 more

4 metrics

Tax-withholding shares 336 shares Shares used in mandated sell-to-cover on June 1, 2026

Average price per share $1.3702 per share Price for the 336-share tax-withholding disposition

Shares held after transaction 1,458,456 shares CEO Albert Benjamin’s direct Common Stock holdings post-transaction

Tax-withholding transactions 1 transaction, 336 shares Form 4 transactionSummary for tax withholding (code F)

Key Terms

Restricted Stock Units, sell to cover, equity incentive plans, tax withholding obligations

4 terms

Restricted Stock Units financial

"in connection with the vesting of Issuer's Restricted Stock Units."

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

sell to cover financial

"to be funded by a "sell to cover" transaction and does not"

Sell to cover is when a person who receives company stock through options or awards sells just enough shares immediately to pay required taxes, exercise costs, or fees, keeping the rest. Think of it like cashing part of a bonus to cover the tax bill so you can keep the remainder. For investors, it can create predictable small selling pressure and slightly change the number of shares actually held by insiders without increasing long‑term dilution.

equity incentive plans financial

"Issuer's election under its equity incentive plans to require the"

Equity incentive plans are company programs that pay employees, executives, or directors with company stock, stock options, or share units instead of or in addition to cash, aiming to align their interests with shareholders—like giving team members a stake in the house they help build. For investors this matters because such plans can motivate better company performance but also dilute existing ownership and increase reported compensation costs, so they affect future earnings, voting power, and share value.

tax withholding obligations financial

"sold by the Reporting Person to cover tax withholding obligations in"

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Albert Benjamin

(Last) (First) (Middle)

10897 S. RIVER FRONT PARKWAY

SUITE 300

(Street)

SOUTH JORDAN UTAH 84095

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Health Catalyst, Inc. [ HCAT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CEO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/01/2026		F		336(1)	D	$1.3702	1,458,456	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

Remarks:

	/s/ Benjamin Landry, as Attorney-in-Fact	06/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did Health Catalyst (HCAT) CEO Albert Benjamin report in this Form 4?

Health Catalyst CEO Albert Benjamin reported a small tax-withholding share disposition. He used 336 Common Stock shares in a mandated “sell to cover” transaction tied to Restricted Stock Unit vesting and continues to hold 1,458,456 shares directly after the event.

How many Health Catalyst (HCAT) shares were used to cover taxes and at what price?

A total of 336 Health Catalyst Common Stock shares were used to cover taxes at an average price of $1.3702 per share. This transaction was required to satisfy tax withholding obligations from the vesting of Restricted Stock Units.

Is the Health Catalyst (HCAT) CEO’s share sale a discretionary transaction?

No, the transaction is not discretionary. The filing explains the shares were required to be sold to satisfy tax withholding obligations upon Restricted Stock Unit vesting under equity incentive plans, as part of a mandated “sell to cover” arrangement.

How many Health Catalyst (HCAT) shares does CEO Albert Benjamin hold after this filing?

Following the tax-withholding disposition, Albert Benjamin directly holds 1,458,456 shares of Health Catalyst Common Stock. The reported 336-share sale was specifically to fund tax withholding on Restricted Stock Unit vesting rather than a broad reduction of his ownership.

What does a Form 4 tax-withholding disposition mean for Health Catalyst (HCAT) investors?

A Form 4 tax-withholding disposition typically reflects routine compensation-related activity. In this case, shares were sold solely to cover tax obligations from Restricted Stock Unit vesting, not as an open-market, discretionary buy or sell decision by the CEO.